Pillstats
Rx only · Patch, Extended Release · Transdermal

Buprenorphine

Brands: Butrans · Buprenorphine

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers7 labelers
Packages30
DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 24 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$14.15$28.30$42.46$56.61Dec 2025Mar 2026Jun 2026
$49.225
Latest avg · Jun 17, 2026
+0%
Since Dec 17, 2025
6
Active US suppliers
38%
Top-2 supplier share*

Who makes it6 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Ingenus Pharmaceuticals, LLCunknown5SUPPLYING
Aveva Drug Delivery Systems Inc.unknown5SUPPLYING
Knoa Pharma LLCunknown5SUPPLYING
Amneal Pharmaceuticals LLCunknown5SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown5SUPPLYING
LTS Therapy Systems, LLCunknown1SUPPLYING
Alvogen Inc.unknown4EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.